Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M215,272Revenue $M49,605Net Margin (%)18.7Altman Z-Score2.8
Enterprise Value $M223,800EPS $1.4Operating Margin %25.9Piotroski F-Score6
P/E(ttm)24.2Beneish M-Score-2.7Pre-tax Margin (%)25.4Higher ROA y-yN
Price/Book3.210-y EBITDA Growth Rate %3.0Quick Ratio2.2Cash flow > EarningsY
Price/Sales4.65-y EBITDA Growth Rate %5.0Current Ratio2.5Lower Leverage y-yN
Price/Free Cash Flow17.1y-y EBITDA Growth Rate %-14.2ROA % (ttm)5.4Higher Current Ratio y-yY
Dividend Yield %3.1PEG4.7ROE % (ttm)12.4Less Shares Outstanding y-yY
Payout Ratio %73.0Shares Outstanding M6,158ROIC % (ttm)12.1Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactup Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PFEFirst Eagle Investment 2014-09-30 Reduce-0.16%$28.04 - $30.96
($29.58)
$ 34.9618%Reduce 94.11%135,661
PFEMichael Price 2014-09-30 Reduce-0.22%$28.04 - $30.96
($29.58)
$ 34.9618%Reduce 56.02%47,100
PFEKahn Brothers 2014-09-30 Reduce-0.59%$28.04 - $30.96
($29.58)
$ 34.9618%Reduce 6.56%1,985,161
PFEHOTCHKIS & WILEY 2014-06-30 Reduce-0.01%$29.02 - $32.4
($30.05)
$ 34.9616%Reduce 33.68%128,800
PFECharles Brandes 2014-06-30 Add0.12%$29.02 - $32.4
($30.05)
$ 34.9616%Add 5.78%6,075,460
PFEJoel Greenblatt 2014-06-30 Add0.27%$29.02 - $32.4
($30.05)
$ 34.9616%Add 71.59%1,741,314
PFEFirst Eagle Investment 2014-06-30 Reduce-0.47%$29.02 - $32.4
($30.05)
$ 34.9616%Reduce 70.71%2,303,762
PFEDodge & Cox 2014-06-30 Reduce-0.5%$29.02 - $32.4
($30.05)
$ 34.9616%Reduce 23.73%48,902,097
PFEVanguard Health Care Fund 2014-06-30 Add0.62%$29.02 - $32.4
($30.05)
$ 34.9616%Add 105.23%14,934,022
PFENWQ Managers 2014-06-30 Reduce-0.81%$29.02 - $32.4
($30.05)
$ 34.9616%Reduce 31.07%6,363,006
PFEFirst Eagle Investment 2014-03-31 Reduce-0.19%$29.66 - $32.75
($31.39)
$ 34.9611%Reduce 22.77%7,866,473
PFEJoel Greenblatt 2014-03-31 Add0.38%$29.66 - $32.75
($31.39)
$ 34.9611%Add 356.54%1,014,808
PFENWQ Managers 2014-03-31 Reduce-0.39%$29.66 - $32.75
($31.39)
$ 34.9611%Reduce 13.60%9,231,207
PFEVanguard Health Care Fund 2014-03-31 Reduce-0.48%$29.66 - $32.75
($31.36)
$ 34.9611%Reduce 40.13%7,276,622
PFEKahn Brothers 2014-03-31 Add0.98%$29.66 - $32.75
($31.36)
$ 34.9611%Add 11.22%2,112,819
PFEDonald Yacktman 2013-12-31 Sold Out -0.01%$28.24 - $32.2
($30.7)
$ 34.9614%Sold Out0
PFERonald Muhlenkamp 2013-12-31 Add0.05%$28.24 - $32.2
($30.7)
$ 34.9614%Add 29.15%45,129
PFEJoel Greenblatt 2013-12-31 Add0.11%$28.24 - $32.2
($30.7)
$ 34.9614%Add 241.71%222,280
PFENWQ Managers 2013-12-31 Reduce-0.12%$28.24 - $32.2
($30.7)
$ 34.9614%Reduce 3.88%10,684,522
PFEDavid Dreman 2013-12-31 Reduce-0.15%$28.24 - $32.2
($30.7)
$ 34.9614%Reduce 85.73%10,163
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PFE is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
OLSON LAURIE JExecutive Vice President 2015-06-11Sell26,000$34.39-0.15view
HILL CHARLES HExecutive Vice President 2015-05-29Sell42,870$34.92-1.66view
SUSMAN SALLYExecutive Vice President 2015-03-12Sell46,179$341view
READ IAN CChairman & CEO 2015-03-05Sell67,500$34.62-0.81view
Dolsten MikaelPresident R&D 2015-03-05Sell58,298$34.46-0.35view
CANGIALOSI LORETTA VSr. Vice President, Controller 2015-02-13Sell104,000$34.73-1.12view
MADDALUNA ANTHONY JExecutive Vice President 2015-02-12Sell9,000$34.85-1.46view
DAMELIO FRANK AExecutive Vice President 2015-02-11Sell80,200$34.230.32view
DAMELIO FRANK AExecutive Vice President 2015-02-11Sell14,800$34.30.12view
MADDALUNA ANTHONY JExecutive Vice President 2015-02-10Sell9,000$33.781.66view

Quarterly/Annual Reports about PFE:

    News about pfe:

    Articles On GuruFocus.com
    It’s Not Too Late To Buy Gilead Sciences Jul 17 2015 
    Perrigo Company Is Strong But Overvalued Jul 15 2015 
    Despite Recent Downgrade, This Ecommerce Giant is a Buy Jun 29 2015 
    Paul Tudor Jones' Top Three Stocks Deliver Positive Returns Jun 24 2015 
    Bristol-Myers Squibb Takes A Step Up On Cancer Drugs, But The Cost Tells A Different Story Jun 22 2015 
    A Look at James Barrow's Investment in Pfizer Jun 16 2015 
    Jim Simons' Top 3 Positions and One That Doubled Return Jun 10 2015 
    Will GlaxoSmithKline Cut Its 6% Dividend? Jun 03 2015 
    Apple, SunEdison and Biogen: Hellman, Jordan Management's Top 3 Stocks Outperform the Rise in the S& May 28 2015 
    Ken Fisher Adds to His Pfizer Position May 27 2015 

    More From Other Websites
    Here’s A List The Major Companies Reporting Earnings Tuesday Jul 27 2015
    Fed Meeting, Twitter Earnings, Consumer Data in Focus Tuesday Jul 27 2015
    Cramer's shopping list for a pullback Jul 27 2015
    What's in Store for Hospira (HSP) this Earnings Season? - Analyst Blog Jul 27 2015
    Will Currency & Generics Weigh on Pfizer (PFE) Q2 Earnings? - Analyst Blog Jul 27 2015
    Allergan signals appetite for new mega deal after $41bn disposal Jul 27 2015
    Merck & Pfizer earnings expectations Jul 27 2015
    What to Look For in Pfizer Earnings Jul 27 2015
    Confluence Life Sciences raises $2.4 million Jul 27 2015
    Dollar Plagues Pharma Earnings But Did Street Get It Right? Jul 27 2015
    Allergan May Turn Sights to Amgen or AbbVie With Cash From Teva Jul 27 2015
    Pfizer And Merck Earnings Previews: Mega-Cap Pharmas Try To Stem Revenue Erosion Jul 27 2015
    Pfizer (PFE) Stock Falls Ahead of Earnings Release Jul 27 2015
    Lilly continues test of HDL cholesterol drug, on panel's advice Jul 27 2015
    Short Sellers Run For Cover From Major Pharma Jul 27 2015
    What to expect from Merck & Pfizer tomorrow Jul 27 2015
    This Healthcare Fund Thinks Large-Caps Are The Best Way To Go Jul 26 2015
    Facebook, Twitter And Exxon Mobil Highlight This Week's Earnings Jul 26 2015
    BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead Jul 26 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    SEENSCO
    ReplySEENSCO - 1 year ago
    PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK